Hi Redant
For years now Admedus has been trying to obtain approval of Cardiocel through Australia's TGA and yet it doesn't happen.
Even a few days after last year's AGM WP went to Canberra to follow up with the TGA people and a few weeks later I recall there was a release of Cardiocell performance data ...... BUT ..... approval is not forthcoming.
Do you have any idea why not? What is their area of concern?
.
What are the positives?, page-12
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.99 |
Change
0.000(0.00%) |
Mkt cap ! $201.0M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.85 | $151.7K | 15.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 464 | $9.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.99 | 7400 | 1 |
View Market Depth
| Last trade - 10.47am 04/02/2025 (20 minute delay) ? |
| AVR (ASX) Chart |